About Michael Jandernoa
Michael Jandernoa is a director at Cirius Therapeutics.
Michael Jandernoa first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Jandernoa in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Jandernoa works with at each company, as listed on that company's latest Form D.
Cirius Therapeutics, Inc. · Form D, Oct 8, 2025
RB
Robert Beardsley
President & CEO
RZ
Robert Zerbe
Director
DA
David Van Andel
Director
JC
Jerry Callahan
Executive officer